Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Senthil, S.
Right arrow Articles by Pugalendi, K. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Senthil, S.
Right arrow Articles by Pugalendi, K. V.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Articles

Cardioprotective Effect of Oleanolic Acid on Isoproterenol-Induced Myocardial Ischemia in Rats

S. Senthil
M. Sridevi
K. V. Pugalendi

Department of Biochemistry, Faculty of Science, Annamalai University, Annamalai Nagar 608 002, Tamil Nadu, India

Correspondence: Address correspondence to: K. V. Pugalendi, Department of Biochemistry, Faculty of Science, Annamalai University, Annamalainagar 608 002, Tamil Nadu, India; e-mail:drkvp{at}sify.com


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
This study was designed to investigate the protective effect of oleanolic acid (OA) against isoproterenol-induced myocardial ischemia in rat myocardium. Wistar strain rats were pretreated with OA (20, 40, and 60 mg/kg, s.c) for 7 days and then intoxicated with isoproterenol (ISO, 85 mg/kg, sc for 2 consecutive days). Heart were excised from the experimental animals and assessed for the activities of marker enzymes [alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), and creatine phosphokinase (CPK)], the levels of lipid peroxide products [thiobarbituric acid reactive substances (TBARS), lipid hydroperoxides (HP) and conjugated dienes (CD)], myeloperoxidase (MPO), lipid profiles [total cholesterol (TC), free cholesterol, ester cholesterol, triglycerides (TG), free fatty acids (FFA) and phospholipids (PL)], and membrane-bound ATPase enzymes (total ATPase, Na+K+ATPase, Ca2+ATPase, and Mg2+ATPase). Troponin T and I were estimated in plasma. Leakage of cardiac markers, elevated lipid peroxidation with increased lipid profiles and decreased activities of membrane-bound ATPase enzymes were confirmed the severe myocardial damage occurring as a consequence of isoproterenol-induced ischemia, and they also showed the significant improvement effected by oleanolic acid pretreatment. These findings provided evidence that oleanolic acid was found to be protecting rat myocardium against ischemic insult and the protective effect could attribute to its anti-oxidative, anti-hyperlipedemic, and anti-arrhythmic properties as well as its membrane-stabilizing action.

Key Words: Oleanolic acid • myocardial ischemia • lipid peroxidation • catecholamine • lipid profiles • ATPase enzymes


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
Catecholamines are of significance not only in normal cardiovascular regulation but also in certain disease states such as congestive heart failure and ischemic heart disease (Raab, 1960; Harrison and Chidsey, 1962). In normal physiological conditions, the circulatory and interstitial catecholamines concentrations in heart are in the nanomolar range. However, pathological conditions such as ischemia, the levels can increase micromolar range (Lameris, 2000). Excessive endogenous release or exogenous administration of catecholamines depletes the energy reserve of cardiac muscle cells. This leads to complex biochemical and structural changes that cause irreversible cellular damage, which is a prelude to necrosis (Rona, 1959).

The model of isoproterenol-induced myocardial ischemia is considered as one of the most widely used experimental model to study the beneficial effects of many drugs and cardiac function (Grimm et al., 1998). The pathophysiological changes following ISO administration are comparable to those taking place in human myocardial ischemia/infarction (Wexler, 1978). It is also well known to generate free radicals and to stimulate lipid peroxidation, which may be a causative factor for irreversible damage to the myocardial membrane (Chatelain et al., 1987). Increases in the formation of reactive oxygen species during ischemia/reperfusion and the adverse effects of oxyradicals on myocardium have now been well established by both direct and indirect measurements. Thus, increased production of reactive oxygen species (ROS) may be a unifying mechanism in ischemic injury progression, and anti-oxidants may be the therapeutic value in this setting.

Myocardial cell protection and prevention of cell ischemia/necrosis have been therapeutic targets for a long time. New therapies are needed to treat myocardial ischemia because current treatment has only a limited impact on survival and annual costs. Triterpenoids exist widely in nature and are the major components of many traditional medicinal herbs. Oleanolic acid (OA) (Figure 1) is a triterpenoid compound that exists widely in food and herbs (Liu, 1995). It has a variety of biological effects, such as anti-oxidants (Balanehru and Nagarajan, 1991), antifungal, anti-inflammatory, anti-hyperlipdemia, hepatoprotective, tumor prevention, immunomodulatory, (Price et al., 1987; Nishino et al., 1988), anti-HIV (Kashiwada et al., 2000), anti-arrhythmic and cardiotonic (Somova et al., 2004). OA has been used successfully to treat liver disease in humans (Hunan Medical Institute, 1997).


Figure 10350418
View larger version (7K):
[in this window]
[in a new window]

  		Figure 1 Structure of oleanolic acid (OA).

 
Due to its anti-oxidant, anti-hyperlipedemic, anti-arrhythmic, and cardiotonic effects, it will provide an accessible and cheap traditional medicine source for treatment of myocardial ischemia in developing countries. Previously we have reported the cardioprotective effect of ursolic acid, an isomer of oleanolic acid, against isoproterenol-induced myocardial ischemia (Senthil et al., 2007). This prompted our research on the anti-ischemic effect of OA in isoproterenol-induced myocardial ischemia.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Chemicals
Oleanolic acid was a gift from the Active Ingredient Group, Inc., Changsha, China. Isoproterenol hydrochloride was purchased from Sigma Chemical Co., St. Louis, Mo, USA. All other chemicals used were of analytical grade.

Animals
Adult male albino rats of Wistar strain, weighing approximately 120–140 g, were used for the experiment. The animals were housed individually in polypropylene cages under hygienic conditions and maintained at room temperature. They all received pellet diet (Amrut Laboratory Animal Feed, M/S. Pranav Agro Industries Ltd., Bangalore, India) and water ad libitum. The experiment was carried out as per the guidelines of Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), New Delhi, India and approved by Institutional Animal Ethics Committee (IAEC), Annamalai University.

Induction of Myocardial Ischemia
Myocardial ischemia was induced by subcutaneous injection of isoproterenol hydrochloride (ISO, 85 mg kg–1 bw), dissolved in physiological saline, for 2 consecutive days (Rona et al., 1959; Seth et al., 1998).

Experimental Protocols
The rats were randomly divided into 6 groups with 8 rats each. The test compound (OA) was completely dissolved in DMSO and diluted with saline by the volume of 5:100 ratio and then used for the experiments. Group 1 served as control (received 5% DMSO sc, for 7 days). Group 2 rats were administered isoproterenol (ISO, 85 mg kg–1 bw, sc, twice at an interval of 24 hours) on 8th and 9th days. Group 3 rats were administered with OA (60 mg kg–1 bw, sc) for 7 days. Groups 4, 5, and 6 rats received 20, 40, and 60 mg kg–1 b.w., of OA, subcutaneously, for 7 days and received ISO (85 mg kg–1 bw, sc, twice at an interval of 24 hours) on the 8th and 9th days, respectively. Twelve hours after the second dose of ISO injection, the rats were sacrificed by cervical decapitation. The heart tissue was excised immediately, washed with chilled isotonic saline, and used for the estimations.

Biochemical Estimations
The activities of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were estimated by the method of Reitman and Frankel (1957). Lactate dehydrogenase (LDH) and creatine phosphokinase (CPK) were determined by the method of King (1965) and Okinaka et al. (1961), respectively, using commercially available kits. Plasma cardiac troponin T and I (cTnT and cTnI) were quantitatively measured by means of a highly specific enzyme immunoassay using commercially available kits (Katus et al., 1991; Larue et al., 1993). The level of thiobarbituric acid reactive substances (TBARS), lipid hydroperoxides (HP), conjugated dienes were estimated by the method of Nichans et al. (1968), Jiang et al. (1992), and Rao and Recknagel (1968), respectively. The neutrophils specific MPO activity was determined by the method of Henson et al. (1978). The levels of total cholesterol, ester cholesterol, triglycerides, phospholipids, and free fatty acids were measured by the method of Allain et al. (1974, commercial kit), Varley et al. (1991), McGowan et al. (1983, commercial kit), Stewart (1980) and Falholt et al. (1973), respectively. The activities of total ATPase, Na+K+ATPase, Ca2+ATPase and Mg2+ATPase were estimated by the method of Evans (1969), Bonting (1970), Hjerken and Pan (1983), and Ohinishi et al. (1982), respectively. The scavenging effect of oleanolic acid was confirmed by the method of Kaur and Saini (2000).

Statistical Analysis
Results are expressed as means ± SD. The data were statistically analyzed by one-way analysis of variance (ANOVA) followed by Duncan’s multiple range test (DMRT) using a statistical package program (SPSS 10.0 for windows), taking p < 0.05 as significant.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
Table 1 shows the scavenging effect (%) of oleanolic acid on superoxide and hydroxyl radicals generated by alkaline DMSO method and Fenton reaction, respectively. Oleanolic acid strongly and dose-dependently scavenged the superoxide and hydroxyl radicals.


View this table:
[in this window]
[in a new window]

  		Table 1 Scavenging effect (%) of oleanolic acid on superoxide and hydroxyl radicals.

 
Table 2 shows the activity of AST, ALT, LDH, and CPK in heart and troponin T and I in plasma of control and experimental rats. Activity of AST, ALT, LDH, and CPK were observed to substantially decrease whereas the level of troponin T and I increased in the isoproterenol-treated group as compared with control. Oleanolic acid pre-treatment (20, 40, and 60 mg kg–1 bw) significantly blocked the decrease of AST, ALT, LDH, and CPK and increase of troponin T and I.


View this table:
[in this window]
[in a new window]

  		Table 2 Activities of heart AST, ALT, LDH, CPK and levels of plasma troponin T and I in control and experimental rats.

 
Table 3 shows the level of TBARS, HP, CD (markers of lipid peroxidation) and myeloperoxidase (marker of neutrophil infiltration) in the heart tissue of control and experimental rats. TBARS, HP, CD, and MPO elevated significantly in the ISO-treated group. Pretreatment with OA prevented the elevation of lipid peroxidation and neutrophil infiltration when compared to untreated ISO group.


View this table:
[in this window]
[in a new window]

  		Table 3 Levels of TBARS, HP, CD, and MPO in the heart of control and experimental rats.

 
Table 4 shows the activities of total ATPase, Na+K+ AT-Pase, Ca2+ ATPase, and Mg2+ ATPase in the heart tissue of control and experimental rats. Total ATPase, Na+K+ AT-Pase, Ca2+ ATPase reduced significantly while decrease in Mg2+ ATPase was not significant in the ISO control group. Pretreatment with OA blocked the decrease of heart ATPase activities.


View this table:
[in this window]
[in a new window]

  		Table 4 Activities of total ATPase, Na+K+ ATPase, Ca2+ATPase, and Mg2+ ATPase in the heart of control and experimental rats.

 
Table 5 shows the level of total cholesterol, free cholesterol, ester cholesterol, triglycerides, free fatty acids, and phospholipids in the heart tissue of control and experimental rats. The level of myocardial lipids except phospholipids showed a significant increase whereas phospholipids decreased significantly in the ISO-treated group. OA pretreatment blocked the amendment of heart lipids to near normal when compared to the untreated ISO group.


View this table:
[in this window]
[in a new window]

  		Table 5 Levels of TC, free, ester cholesterol, TG, PL, and FFA in the heart of control and experimental rats.

 
In all the parameters studied, OA had the highest activity, at the medium dose of 40 mg kg–1, than the other 2 doses (20 and 60 mg kg–1).


   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
Isoproterenol produces relative ischemia or hypoxia due to myocardial hyperactivity and coronary hypotension (Bloom and Davis, 1972), and induce myocardial ischemia due to cytosolic Ca2+ overload (Singal et al., 1983). The oxidative stress may be exerted through quinone metabolites of isoproterenol, which reacts with oxygen to produce ROS (Rathore et al., 1998) and interfere with glutathione reductase (Remiao et al., 2000), superoxide dismutase (Rathore et al., 1998), and ATP pumps (Remiao et al., 2000).

When myocardial cells, containing AST, ALT, CPK, and LDH, are damaged or destroyed due to deficient oxygen supply or glucose, the cell membrane becomes permeable or may rupture, which results in the leakage of enzymes. This accounts for the decreased activities of these enzymes in heart of rats with myocardial ischemia-induced by isoproterenol. This might be due to the damage caused to the sarcolemma by the β-agonist that has rendered it leaky (Mathew, 1985). Furthermore, the level of plasma troponin T and I were increased in ISO-treated rats and our finding was in consonance with an earlier report (Acikel et al., 2004). It is more likely that the plasma levels of troponin found in patients with unstable angina pectoris provide information about the severity of myocardial ischemia that caused cellular troponin degradation and release of troponin degradation products in the circulation (Van Der Laarse, 2002).

The OA pretreatment blocked the decrease of marker enzymes and increase of plasma troponins significantly, indicating the cytoprotective activity of OA and effect on recovery. Oleanolic acid is a lipophilic β-blocker in nature. β-Adrenergic blockers have long been useful adjuvants in the management of myocardial ischemic syndromes. The therapeutic benefits of β-blockers in patients with heart failure have been demonstrated in the CIBIS-II (1999) and MERIT-HF (1999) trials. The lipophilic β-blocking drugs intercalate into the lipid matrix and impart stabilization to myocardial cell membranes in relation to the degree of lipophilicity (Cruickshank and Dweyer, 1985). Hence, it is possible that likewise OA may also prolong the viability of myocardial cell membranes from necrotic damage by its membrane-stabilizing action (Han et al., 1997).

The myocardial necrosis observed in the animals receiving isoproterenol can also be attributed to peroxidative damage as it has been previously reported that isoproterenol generates lipid peroxides (Blasig et al., 1984). Our present observations were in keeping with the previous findings indicating the increases of lipid peroxidation. Oleanolic acid pretreatment prevent the elevation of myocardial lipid peroxides by an apparent direct scavenging of superoxide and hydroxyl radicals (Table 1) thereby prevent the initiation and propagation of the lipid peroxidation process (Balanehru and Nagarajan, 1991).

It was noticed earlier that the neutrophils, a major source of free radicals, characteristically invaded the myocardial tissue during ischemia (Abe et al., 1999). The observations of this study showing that oleanolic acid pretreatment blocked the elevation of MPO activity indicated that OA suppressed neutrophils infiltration into the injured myocardium. The inhibition of neutrophils infiltration and its function resulting in reduced generation of oxygen free radicals, during ischemia, may contribute to the protective action of oleanolic acid against myocardial ischemia.

Lipid metabolism plays an important role in myocardial necrosis produced by ischemia (Mathew et al., 1981). Isoproterenol-treated rats showing altered lipid profiles in the heart agrees well with a previous report (Subhash et al., 1978). The significant increase observed in the lipid profiles except phospholipids in the rat treated with ISO alone could be due to enhanced lipid biosynthesis by cardiac cAMP. Changes in membrane cholesterol content affect its fluidity, permeability to ions, activities of membrane-bound enzymes, and increased degradation of phospholipids (Yeagle, 1985). In this study, OA pretreatment was shown to block the alterations of myocardial lipids. This could be due to the ability of oleanolic acid to inhibit cAMP and thereby maintain the normal fluidity and less alteration in the property and function of the myocardial membrane (Wang et al., 1996).

Biological membranes are rich in phospholipids. A significant increase in free fatty acids and a decrease in phospholipid content in ISO-treated rats might have been due to the breakdown of membrane phospholipids. Accelerated phospholipid degradation could produce membrane dysfunction, resulting in cell injury and ultimate cell death. OA pretreatment significantly prevented the degradation of phospholipids thereby increases phospholipids and decrease the ratio of cholesterol/phospholipids (C/P ratio).

Besides lipids, ATPases pay significant role in the contraction and relaxation cycles of the cardiac muscle by maintaining normal ion levels within the myocyte. Several factors are known to alter the levels of ATPase, especially lipid peroxidation and membrane fluidity. It has been reported that ISO treatment resulted in a decrease in the activities of membrane-bound ATPases (Chernysheva et al., 1980). The results obtained in this study also correlates with the preceding reports. The loss of ATPase activity in the ischemic state may be responsible for causing not only functional damage but also reversible necrotic changes in the involved myocardial cell. Hebbel et al. (1986) have correlated the inactivation of membrane-bound enzymes with peroxidation of membrane lipids. Peroxidation of membrane lipids could inactivate Na+K+ ATPase and Ca2+ATPase because of the oxidation of ‘SH’ groups present in its active site leading to the conformational alteration in the enzymes (Kako et al., 1988). Decrease in the activity of Ca2+ATPase can increase intracellular concentration of free Ca2+ and alter the signal transduction pathways and cellular fluidity (Levy et al., 1986).

The present study shows that the altered activity of the membrane-bound phosphatases by isoproterenol was protected by pretreatment with oleanolic acid. This could be due to the anti-oxidative effect of OA against ROS induced by ISO. The results of this study imply that oleanolic acid pretreatment proved to be effective in reducing the extent of myocardial damage by decreasing lipid peroxidation, prevent the overloading of myocardium with lipids and its β-blocking activity.


   Acknowledgments
 
We are thankful to Dr. Dragon Chang, Active Ingredients Group, Inc. (AIGI), Changsha, China for the generous gift of oleanolic acid.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Abe, Y, Hashimato, S, & Horie, T. (1999). Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol Res, 39, 41-7[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Acikel, M, Buyukokuroglu, ME, Erdogan, F, Akosy, H, Bozkurt, E, & Senocak, H. (2005). Protective effect of dantrolene against myocardial injury induced by isoproterenol in rats: biochemical and histological findings. Int J Cardiol, 98, 389-94[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Allain, CC, Poon, LS, Chan, CSG, Richmond, W, & Fu, PC. (1974). Enzymatic determination of total serum cholesterol. Clin Chem, 20, 470-5[Abstract]

Balanehru, S, & Nagarajan, B. (1991). Protective effect of oleanolic acid and ursolic acid against lipid peroxidation. Biochem Int, 24, 981-90[Web of Science][Medline] [Order article via Infotrieve]

Blasig, IE, Blasig, R, & Lowe, H. (1984). Myocardial lipid peroxidation during isoproterenol-induced blood flow reduction in rat myocardium. Biomed Biochim Acta, 43, S171-4[Web of Science][Medline] [Order article via Infotrieve]

Bloom, S, & Davis, DL. (1972). Calcium as mediator of isoproterenol-induced myocardial necrosis. Am J Pathol, 69, 459-70[Web of Science][Medline] [Order article via Infotrieve]

Bonting, SL. (1970). Presence of Enzyme System in Mammalian Tissues. Membranes and Ion Transport (pp.25-8). London: Wiley-Interscience

Chatelain, P, Gremel, M, & Brotelle, R. (1987). Prevention of amiodarone of phospholipid depletion in isoproterenol-induced ischemia in rats. Eur J Pharmacol, 144, 83-90[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Chernysheva, GV, Stoida, LV, Amaranrova, GG, & Kuz’mina, IL. (1980). Effect of disseminated myocardial necrosis on ATPase activity, Ca2+ transport, and lipid peroxidation in cardiac mitochondrial and microsomal membranes. Biull Eksp Biol Med, 89, 563-5

CIBIS-II Investigators and Committees. (1999). The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomized trial. Lancet, 353, 9-13[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Cruickshank, JM, & Dweyer, NG. (1985). β-blocker brain concentration in man. Eur J Clin Pharmacol, 28, 21-3[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Evans, WH. (1969). Membrane adenosine triphosphatase of E. coli activation by calcium ions and inhibition by monovalent cations. J Bacteriol, 100, 914-22[Abstract/Free Full Text]

Falholt, K, Lund, B, & Falholt, W. (1973). An easy colorimetric micro-method for routine determination of free fatty acids in plasma. Clin Chim Acta, 46, 105-11[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Grimm, D, Elsner, D, Schunkert, H, et al. (1998). Development of heart failure following isoproterenol administration in the rat: role of reninangiotensin system. Cardiovas Res, 37, 91-100[Abstract/Free Full Text]

Han, SK, Ko, YI, Park, SJ, Jin, IJ, & Kim, JM. (1997). Oleanolic acid and ursolic acid stabilize liposomal membranes. Lipids, 32, 769-73[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Harrison, DC, & Chidsey, CA. (1962). Assessment of sympathetic nervous system activity during exercise in congestive heart failure. Circulation, 26, 729

Hebbel, RP, Shalev, O, Foker, W, & Rank, BH. (1986). Inhibition of erythrocyte Ca2+ ATPase by activated oxygen through thiol-and lipid dependent mechanisms. Biochem Biophys Acta, 862, 8-16[Medline] [Order article via Infotrieve]

Henson, PM, Zanolari, B, Schwartzmann, NA, & Honf, SR. (1978). Intracellular control of human neutrophils secretion. J Immunol, 121, 851-5[Abstract/Free Full Text]

Hjerken, S, & Pan, H. (1983). Purification and characterization of two forms of a low affinity calcium ion-ATPase from erythrocyte membrane. Biochem Biophys Acta, 728, 281-8[Medline] [Order article via Infotrieve]

Human Medical Institute. (1997). Effects of oleanolic acid on experimental liver injury and acute hepatitis in humans. Tradit Med, 8, 32-7

Jiang, ZY, Hunt, JV, & Wolff, SP. (1992). Detection of lipid hydroperoxides using the ‘fox method’. Anal Biochem, 202, 384-9[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Kako, K, Kato, M, Matsuoko, T, & Mustapha, A. (1988). Depression of membrane-bound Na+K+-ATPase activity induced by free radicals and by ischemia of kidney. Am J Physiol, 254, C330-7[Web of Science][Medline] [Order article via Infotrieve]

Kashiwada, Y, Wang, HK, Nagao, T, Kitanaka, S, Yasuda, I, Fujioka, T, Yamagishi, T, Cosentino, LM, Kozuka, M, Okabe, H, Ikeshiro, Y, Hu, C, Yeh, E, & Lee, KH. (1998). Anti-AIDS agents. 30. Anti-HIV activity of oleanolic acid, pomic acid, and structurally related triterpenoids. J Nat Prod, 61, 1090-5[CrossRef][Medline] [Order article via Infotrieve]

Katus, HA, Remppis, A, Neumann, FJ, Scheffold, T, Diederich, KW, Vinar, G, et al. (1991). Diagnostic efficacy of troponin T measurements in acute myocardial infarction. Circulation, 83, 902-12[Abstract/Free Full Text]

Kaur, IP, & Saini, A. (2000). Sesamol exhibits antimutagenic activity against oxygen species mediated mutagenicity. Mutat Res, 470, 71-6[Web of Science][Medline] [Order article via Infotrieve]

King, J. (1965). The dehydrogenases or oxidoreductase. Lactate dehydrogenase. Practical Clinical Enzymology (pp.106, London: Van Nostrand

Lameris, TW, Zeeuw, SD, Alberts, G, Boomsma, F, Duncker, DJ, Verdouw, PD, Veld, AJM, & Meiracker, AH. (2000). Time course and mechanism of myocardial catecholamine release during transient ischemia in vivo. Circulation, 101, 2645-50[Abstract/Free Full Text]

Larue, C, Calzolari, C, Bertinchant, JP, Leclercq, F, Grolleau, R, & Pau, B. (1993). Cardiac-specific immunoenzymomimetic assay of troponin I in the early phase of acute myocardial infarction. Clin Chem, 39, 972-9[Abstract/Free Full Text]

Levy, J, Gavin, JR, Hammerman, MR, & Avioli, LV. (1986). Ca2+, Mg2+ ATPase activity in kidney basolateral membrane in non-insulin dependent diabetic rats: effect of insulin. Diabetes, 35, 899-905[Abstract]

Liu, J. (1995). Pharmacology of oleanolic acid and ursolic acid. J Ethnopharmacol, 49, 57-68[Web of Science][Medline] [Order article via Infotrieve]

Mathew, S, Menon, PVG, & Kurup, PA. (1981). Changes in myocardial and aortic lipids, lipolytic activity and fecal excretion of sterols and bile acids in isoproterenol-induced myocardial infarction in rats. Ind J Biochem Biophys, 18, 131-3[Web of Science][Medline] [Order article via Infotrieve]

Mathew, S, Menon, RVG, & Kurup, PA. (1985). Effect of administration of vitamin A, ascorbic acid and nicotinamide adenine dinucleotide + flavin adenine nucleotide on severity of myocardial infarction induced by isoproterenol in rats. Ind J Biol, 23, 500-4

McGowan, MW, Artiss, JD, Strandbergh, DR, & Zak, B. (1983). A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem, 29, 538-42[Abstract/Free Full Text]

MERIT-HF Study Group. (1999). Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet, 353, 2001-7[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Nichans, WG, & Samuelson, B. (1968). Formation of malondialdehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur J Biochem, 6, 126-30[Web of Science][Medline] [Order article via Infotrieve]

Nishino, H, Nishino, A, Takayasu, J, Hasegawa, T, Iwashima, A, Hirabayashi, K, Iwata, S, & Shibata, S. (1988). Inhibition of the tumor-promoting action of 12-O-tetradecanoylphorbol-13-acetate by some oleanane-type triterpenoid compounds. Cancer Res, 48, 5210-5[Abstract/Free Full Text]

Ohinishi, T, Suzuki, T, Suzuki, Y, & Ozawa, K. (1982). A comparative study of plasma membrane magnesium ion ATPase activity in normal, regenerating and malignant cells. Biochim Biophys Acta, 684, 67-74[Medline] [Order article via Infotrieve]

Okinaka, S, Kumagai, H, Ebashi, S, Sugita, H, Momoi, H, Toyokura, Y, & Fujie, Y. (1961). Serum creatine phosphokinase. Activity in progressive muscular dystrophy and neuromuscular diseases. Arch Neurol, 4, 520-5[Abstract/Free Full Text]

Price, KR, Jonshon, IT, & Fenwick, GR. (1987). The chemistry and biological significance of saponins in foods and feeding stuffs. Crit Rev Food Sci Nutr, 26, 27-135[Medline] [Order article via Infotrieve]

Raab, W. (1960). Key position of catecholamine in functional and degenerative cardiovascular pathology. Am J Cardiol, 5, 571[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Ramos, K, & Acosta, D. (1982). Prevention by L(–) ascorbic acid of isoproterenol-induced cardiotoxicity in primary cultures of rat myocytes. Toxicology, 26, 81-90[CrossRef][Web of Science]

Rao, KS, & Recknagel, RO. (1968). Early onset of lipid peroxidation in rat liver after carbon tetrachloride administration. Exp Mol Pathol, 9, 271-8[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Rathore, N, John, S, Kale, M, & Bhatnagar, D. (1998). Lipid peroxidation and antioxidant enzymes in isoproterenol induced oxidative stress in rat tissues. Pharmacol Res, 38, 297-303[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Reitman, S, & Frankel, S. (1957). A colorimetric method for the determination of serum glutamate oxaloacetic and glutamate pyruvic transaminases. Am J Clin Pathol, 28, 56-63[Web of Science][Medline] [Order article via Infotrieve]

Remiao, F, Carmo, H, Carvalho, FD, & Bastos, ML. (2000). Inhibition of glutathione reductase by isoproterenol oxidation products. J Enzyme Inhibit, 15, 47-61

Rona, G, Chappel, CT, Balaz, T, & Gaudry, R. (1959). An infarct like myocardial lesion and other true manifestation produced by isoproterenol in the rat. Arch Pathol, 67, 433-55

Sawyer, DB, Siwik, DA, Xiao, L, Piementel, DR, Singh, K, & Colucci, WS. (2002). Role of oxidative stress in myocardial hypertrophy and failure. J Mol Cell Cardiol, 34, 379-88[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Senthil, S, Sridevi, M, & Pugalendi, KV. (2007). Protective effect of ursolic acid against myocardial ischemia induced by isoproterenol in rats. Toxicol Mech Meth, 17, 1-9

Seth, SD, Maulik, M, Katiyar, CK, & Maulik, SK. (1998). Role of lipistat in protection against isoproterenol induced myocardial necrosis in rats: a biochemical and histological study. Ind J Physiol Pharmacol, 42, 101-6[Medline] [Order article via Infotrieve]

Singal, PK, Beamish, RE, & Dhalla, NS. (1983). Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease. Adv Exp Med Biol, 161, 391-401[Web of Science][Medline] [Order article via Infotrieve]

Somova, LI, Shode, FO, & Mipando, M. (2004). Cardiotonic and antidysrhythmic effects of oleanolic acid and ursolic acids, methyl maslinate and uvaol. Phytomedicine, 11, 121-9[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Stewart, JCM. (1980). Colorimetric determination of phospholipids, with ammonium ferrocyanate. Anal Biochem, 104, 10-14[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Subhash, DS, Narinder, KK, & Nityanand, S. (1978). Effect of isoprenaline on lipid profile and cardiac enzymes in rats. Ind J Exp Biol, 16, 376-8[Web of Science][Medline] [Order article via Infotrieve]

Van Der Laarse, A. (2002). Hypothesis: troponin degradation is one of the factors responsible for deterioration of left ventricular function in heart failure. Cardiovas Res, 56, 8-14[Abstract/Free Full Text]

Varley, H, Gowenlock, AH, & Bell, M. In Varley, H (Ed.). (1991). Determination of free and ester cholesterol. Practical Biochemistry (pp.311-6). New Delhi: CBS Publishers

Wang, BH, & Polya, GM. (1996). Selective inhibition of cyclic AMP dependent protein kinase by amphypylic triterpenoids and related compounds. Phytochem, 41, 55-63[CrossRef]

Wexler, BC, & Greenberg, BP. (1978). Protective effects of clofibrate on isoproterenol-induced myocardial infarction in arteriosclerotic and non-arteriosclerotic rats. Atherosclerosis, 29, 373-95[Medline] [Order article via Infotrieve]

Yates, JC, Taam, GML, Singal, PK, Beamish, RE, & Dhalla, NS. (1980). Protection against adrenochrome-induced myocardial damage by various pharmacological interventions. Brit J Exp Pathol, 61, 242-55[Web of Science][Medline] [Order article via Infotrieve]

Yeagle, PL. (1985). Cholesterol and the cell membrane. Biochim Biophys Acta, 822, 267-87[Medline] [Order article via Infotrieve]

Toxicologic Pathology, Vol. 35, No. 3, 418-423 (2007)
DOI: 10.1080/01926230701230312
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Senthil, S.
Right arrow Articles by Pugalendi, K. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Senthil, S.
Right arrow Articles by Pugalendi, K. V.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?